basal cell carcinoma

Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

Related to basal cell carcinoma: squamous cell carcinoma, melanoma

?Note: This page may contain content that is offensive or inappropriate for some readers.

basal cell carcinoma

A slow-growing, locally invasive, but rarely metastasizing neoplasm of the skin derived from basal cells of the epidermis or hair follicles.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

ba′sal cell` carcino′ma

a common and usu. curable skin cancer that arises from basal cells of the epithelium.

Translations

ba·sal cell car·ci·no·ma

n. carcinoma de célula basal, neoplasma epitelial de crecimiento moderado invasivo derivado de células basales de la epidermis o de folículos pilosos.

English-Spanish Medical Dictionary © Farlex 2012

Mentioned in ?

skin cancers

References in periodicals archive ?

This section of the report also provide insights into the key trends of the basal cell carcinoma treatment market such as augmentation in clinical trials, increase in private insurance and favorable reimbursement scenario.

Basal Cell Carcinoma Treatment Market Size, Share, Trends and Future Growth Predictions and Forecast

Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma. Clin Ther.

Treatments Beyond Localized Skin Surgery for BCC, SCC, and Localized Melanoma

The "Market Spotlight: Basal Cell Carcinoma" report has been added to ResearchAndMarkets.com's offering.

Global Basal Cell Carcinoma Market Spotlight Report 2019 Featuring Sun Pharmaceutical, Novartis, Roche, & Valeant Pharmaceuticals

Medivir AB (STO:MVIR), a developer of drugs with a focus on cancer where the unmet medical needs are high, reported on Monday that positive data from the investigator-initiated study evaluating the effects of remetinostat in basal cell carcinoma (BCC) patients has been presented at the 2019 Society for Investigative Dermatology (SID) annual meeting in Chicago, US.

Medivir to present positive data from the remetinostat phase II study in basal cell carcinoma at SID Annual meeting at Chicago, US

Basal cell carcinoma (BCC) is the most common malignant neoplasm of the skin.

Polypoid basal cell carcinoma on the right groin: A case report and review of literature

Long term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up.

Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins

On histological analysis,the most common skin malignancy noted was basal cell carcinoma comprising 45 cases (45%), followed by squamous cell carcinoma comprising 25 cases (25%).

FREQUENCY AND HISTOLOGICAL PATTERN OF MALIGNANT SKIN LESIONS IN PAKISTANI POPULATION

The objective of the study is to analyse the different histopathological patterns of Basal Cell Carcinoma (BCC) in 30 consecutive cases of basal cell carcinoma.

HISTOPATHOLOGICAL ANALYSIS OF BASAL CELL CARCINOMA

A biopsy was performed and microscopic examination demonstrated a pigmented basal cell carcinoma. The patient underwent wide excision, yielding a 4.0 x 1.2 x 0.6 cm tissue sample with negative margins.

Basal cell carcinoma and malignant melanoma cutaneous collision tumor

Basal cell carcinoma (BCC) is the most common skin cancer especially in populations with fair skin color.

Clinical and Demographic Features of Basal Cell Carcinoma in North Jordan

Basal cell carcinoma (BCC) of the skin is the most common human cancer in Caucasians.